Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Diassess Inc.

Request full access

Next Generation Rapid DNA Testing

Emeryville, United StatesFounded 2013Biotech & Life Sciences

About Diassess Inc.

Diassess Inc., which has been rebranded as Lucira Health, is a company that focuses on the development of disposable and inexpensive hardware for health diagnostics. This hardware is designed to turn any smartphone into a portable device for real-time health monitoring.

The company's technology allows for the rapid and accessible analysis of bodily fluids, which can be done anywhere in the world. This is aimed at changing how infectious diseases are prevented, diagnosed, and monitored, by giving individuals the tools to gain knowledge about their own health status.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
None listed
Dealroom signal
58.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Testing, Biotechnology, DNA, Genetics and genomics, Spinout, Genome Engineering, Biotech and Pharma, YC W15, medical testing, DT and LS
Technology
Big Data
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Jul 2018 $22M — Undisclosed —
SERIES A✓Equity / VC Oct 2015 $13M $52M DHVC (Danhua Capital) · Eclipse Ventures · StartX · Hedgewood —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Diassess Inc. website traffic

Latest recorded traffic for Diassess Inc. is 0 monthly website visits. Diassess Inc.'s team declined 33.3% over the past year.

Latest monthly visits0 1-year team growth-33.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Transplant GenomicsBiotech company that focuses on improving organ transplant outcomes Los Angeles, United States Operational 58 $8.1M —
Multiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine Antwerp, Belgium Acquired
QuetheraGene therapy company dedicated to improving the future treatment of common blinding eye diseases Canterbury, United Kingdom Acquired
Pathogen DXDevelops a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets Scottsdale, United States Operational
Singlera GenomicsA developer of 'liquid biopsy'​ analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA San Diego, United States Operational
MDNA Life SciencesProviding accurate disease testing using mitochondrial dna West Palm Beach, United States Operational
CareDxInnovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey Brisbane, United States Operational
CancerGuide DiagnosticsMolecular diagnostics company developing genomic-based clinical and pharmaceutical cancer tests and services Durham, United States Closed
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Diassess Inc. in the Emeryville ecosystem

Live from Dealroom

The Diassess Inc. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A4 investors entered at this stage

Other known investors2 additional known investors

  • University of California, Berkeley
  • Cristian Hernandez-Cuevas
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Diassess Inc. on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Diassess Inc.’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.